8/12/24 17:23 | 8/9/24 | GANX | Health | Drug | Pharmaceutical Preparations | Mack Gene | MD | O | CFO,Inte | P | 15 | 1.01 | 0 | 14 | New | 14 | D | | | | | | | | | | | | | | |
8/12/24 17:23 | 8/9/24 | GANX | Health | Drug | Pharmaceutical Preparations | Islam Khalid | MD | DO | Exec CB | P | 50 | 0.9988 | 0 | 50 | 6 | 931 | D | | | | | | | | | | | | | | |
7/1/24 17:00 | 7/1/24 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | D | | P | 21 | 1.22 | 0 | 17 | 6 | 304 | D | | | | | | | | | | | | | | |
4/1/24 16:01 | 3/28/24 | GANX | Health | Drug | Pharmaceutical Preparations | Riley Jeffrey Scott | MD | D | | P | 116 | 3.86 | 0 | 30 | New | 30 | D | | | | | | | | | | | | | | |
3/28/24 21:00 | 3/26/24 | GANX | Health | Drug | Pharmaceutical Preparations | Alder Matthias | MD | DO | CEO | M.d | 0 | 0.00 | 0 | 20 | 999% | 21 | D | | | | | | | | | | | | | | |
12/22/23 16:17 | 12/21/23 | GANX | Health | Drug | Pharmaceutical Preparations | Alder Matthias | MD | DO | CEO | S.d | -1 | 2.46 | 0 | 0 | -4 | 5 | D | | | | | | | | | | | | | | |
12/22/23 16:17 | 12/20/23 | GANX | Health | Drug | Pharmaceutical Preparations | Alder Matthias | MD | DO | CEO | M.d | 0 | 0.00 | 0 | 1 | 14 | 5 | D | | | | | | | | | | | | | | |
12/14/23 16:01 | 12/7/23 | GANX | Health | Drug | Pharmaceutical Preparations | Alder Matthias | MD | DO | CEO | S | -5 | 2.50 | 0 | -2 | -27 | 5 | D | | | | | | | | | | | | | | |
10/3/23 16:36 | 10/1/23 | GANX | Health | Drug | Pharmaceutical Preparations | Alder Matthias | MD | DO | CEO | M.d | 0 | 0.00 | 0 | 1 | 14 | 7 | D | | | | | | | | | | | | | | |
9/22/23 16:34 | 9/20/23 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | D | | M.d | 0 | 0.00 | 0 | 55 | 24 | 287 | D | | | | | | | | | | | | | | |
9/22/23 16:34 | 9/20/23 | GANX | Health | Drug | Pharmaceutical Preparations | Alder Matthias | MD | DO | CEO | M.d | 0 | 0.00 | 0 | 3 | 77 | 6 | D | | | | | | | | | | | | | | |
7/5/23 16:18 | 7/1/23 | GANX | Health | Drug | Pharmaceutical Preparations | Alder Matthias | MD | DO | CEO | M.d | 0 | 0.00 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
5/27/22 16:10 | 5/25/22 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | DO | CEO | P | 6 | 2.58 | 0 | 2 | 1 | 233 | D | | | | | | | | | | | | | | |
5/23/22 16:41 | 5/19/22 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | DO | CEO | P.m | 37 | 2.79 | 0 | 13 | 6 | 230 | D | | | | | | | | | | | | | | |
5/23/22 16:00 | 5/19/22 | GANX | Health | Drug | Pharmaceutical Preparations | Calabrese Salvatore | MD | O | CFO | P.a | 8 | 2.70 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
5/19/22 17:00 | 5/19/22 | GANX | Health | Drug | Pharmaceutical Preparations | Calabrese Salvatore | MD | O | CFO | P.e | 8 | 2.70 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
4/21/22 16:50 | 8/16/21 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | DO | CEO | P.a | 39 | 7.87 | 0 | 5 | 2 | 217 | D | | | | | | | | | | | | | | |
8/17/21 21:03 | 8/16/21 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | D | | M | 39 | 7.87 | 0 | 5 | 2 | 217 | D | | | | | | | | | | | | | | |